The copper-catalyzed H-F insertion into α-diazocarbonyl compounds is described using potassium fluoride (KF) and hexafluoroisopropanol. Access to complex α-fluorocarbonyl derivatives is achieved under mild conditions, and the method is readily adapted to radiofluorination with [(18)F]KF. This late-stage strategy provides an attractive route to (18)F-labeled biomolecules.
Substrate-directable reactions play a pivotal role in organic synthesis, but are uncommon in reactions proceeding via radical mechanisms. Herein, we provide experimental evidence showing dramatic rate acceleration in the Sm(II)-mediated reduction of cyclic esters that is enabled by transient chelation between a directing group and the lanthanide center. This process allows unprecedented chemoselectivity in the reduction of cyclic esters using SmI2-H2O and for the first time proceeds with a broad substrate scope. Initial studies on the origin of selectivity and synthetic application to form carbon-carbon bonds are also disclosed.
The presence of HMPA is critical for the selective coupling of alkyl halides and ketones by SmI2. Although previous rate studies have shown that HMPA dramatically accelerates the reduction of alkyl halides over ketones, the basis of this rate acceleration is unknown. In this communication, we report experimental and computational evidence that demonstrate that the selectivity observed in the samarium Barbier reaction is in part a result of activation of the alkyl halide bond by HMPA.
The addition of catalytic amounts of Ni(II) salts provide enhanced reactivity and selectivity in numerous reactions of SmI(2), but the mechanistic basis for their effect is unknown. We report spectroscopic and kinetic studies on the mechanistic role of catalytic Ni(II) in the samarium Barbier reaction. The mechanistic studies presented herein show that the samarium Barbier reaction containing catalytic amounts of Ni(II) salts is driven solely by the reduction of Ni(II) to Ni(0) in a rate-limiting step. Once formed, Ni(0) inserts into the alkyl halide bond through oxidative addition to produce an organonickel species. During the reaction, the formation of colloidal Ni(0) occurs concomitantly with Ni(0) oxidative addition as an unproductive process. Overall, this study shows that a reaction thought to be driven by the unique features of SmI(2) is in fact a result of known Ni(0) chemistry.
Electron transfer from the ground and excited states of Sm[15-crown-5](2)I(2) complex to a series of electron acceptors (benzaldehyde, acetophenone, benzophenone, nitrobenzene, benzyl bromide, benzyl chloride, 1-iodohexane, and 1,4-dinitrobenzene) was investigated in acetonitrile. Electron transfer from the ground state of the Sm(II)-crown system to aldehydes and ketones has a significant inner sphere component indicating that the oxophilic nature of Sm(II) prevails in the system even in the presence of bulky ligands such as 15-crown-5 ether. Activation parameters for the ground state electron transfer were determined, and the values were consistent with the proposed mechanistic models. Since crown ethers stabilize the photoexcited states of Sm(II), the photochemistry of Sm[15-crown-5](2)I(2) system in solution state has been investigated in detail. The results suggest that photoinduced electron transfer from Sm(II)-crown systems to a wide variety of substrates is feasible with rate constant values as high as 10(7) M(-1) s(-1). The results described herein imply that the present difficulty of manipulating the extremely reactive excited state of Sm(II) in solution phase can be overcome through stabilizing the excited state of the divalent metal ion by careful design of the ligand systems.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.